BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 23219768)

  • 21. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nailfold video-capillaroscopy in systemic sclerosis.
    Cutolo M; Pizzorni C; Sulli A
    Z Rheumatol; 2004 Dec; 63(6):457-62. PubMed ID: 15605209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
    Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
    Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-evaluation of nailfold capillaroscopy in discriminating primary from secondary Raynaud's phenomenon and in predicting systemic sclerosis: a randomised observational prospective cohort study.
    Amaral MC; Paula FS; Caetano J; Ames PR; Alves JD
    Expert Rev Clin Immunol; 2024 Jun; 20(6):665-672. PubMed ID: 38465507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capillaroscopy.
    Cutolo M; Pizzorni C; Sulli A
    Best Pract Res Clin Rheumatol; 2005 Jun; 19(3):437-52. PubMed ID: 15939368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laser Doppler perfusion imaging is useful in the study of Raynaud's phenomenon and improves the capillaroscopic diagnosis.
    Rosato E; Borghese F; Pisarri S; Salsano F
    J Rheumatol; 2009 Oct; 36(10):2257-63. PubMed ID: 19684154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients.
    Sulli A; Secchi ME; Pizzorni C; Cutolo M
    Ann Rheum Dis; 2008 Jun; 67(6):885-7. PubMed ID: 18037628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders.
    Murray AK; Moore TL; Manning JB; Taylor C; Griffiths CE; Herrick AL
    Arthritis Rheum; 2009 Aug; 61(8):1103-11. PubMed ID: 19644893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis.
    Cutolo M; Sulli A; Pizzorni C; Accardo S
    J Rheumatol; 2000 Jan; 27(1):155-60. PubMed ID: 10648032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computerized nailfold video capillaroscopy--a new tool for assessment of Raynaud's phenomenon.
    Anderson ME; Allen PD; Moore T; Hillier V; Taylor CJ; Herrick AL
    J Rheumatol; 2005 May; 32(5):841-8. PubMed ID: 15868619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nail-fold capillaroscopy in dermatology].
    Senet P; Fichel F; Baudot N; Gaitz JP; Tribout L; Frances C
    Ann Dermatol Venereol; 2014; 141(6-7):429-37. PubMed ID: 24951141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon.
    Pavlov-Dolijanovic S; Damjanov NS; Stojanovic RM; Vujasinovic Stupar NZ; Stanisavljevic DM
    Rheumatol Int; 2012 Oct; 32(10):3039-45. PubMed ID: 21901350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy.
    Ingegnoli F; Boracchi P; Gualtierotti R; Biganzoli EM; Zeni S; Lubatti C; Fantini F
    Rheumatology (Oxford); 2010 Apr; 49(4):797-805. PubMed ID: 20100796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of nailfold capillary abnormalities in patients with connective tissue diseases.
    Ohtsuka T
    Int J Dermatol; 1999 Oct; 38(10):757-64. PubMed ID: 10561047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to perform and interpret capillaroscopy.
    Cutolo M; Sulli A; Smith V
    Best Pract Res Clin Rheumatol; 2013 Apr; 27(2):237-48. PubMed ID: 23731933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of capillaroscopy in differentiation of primary and secondary Raynaud's phenomenon in rheumatic diseases: a review of the literature and two case reports.
    Lambova SN; Müller-Ladner U
    Rheumatol Int; 2009 Sep; 29(11):1263-71. PubMed ID: 19547979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud's disease.
    Nagy Z; Czirják L
    J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):62-8. PubMed ID: 14678534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Diagnostic and Predictive Value of Capillaroscopy in Systemic Sclerosis.
    Cutolo M; Pizzorni C; Sulli A; Smith V
    Curr Rheumatol Rev; 2013; 9(4):249-53. PubMed ID: 26932289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methods for the morphological and functional evaluation of microvascular damage in systemic sclerosis.
    Ruaro B; Smith V; Sulli A; Decuman S; Pizzorni C; Cutolo M
    Korean J Intern Med; 2015 Jan; 30(1):1-5. PubMed ID: 25589827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al.
    Cutolo M; Pizzorni C; Sulli A
    Arthritis Rheum; 2007 Jun; 56(6):2102-3; author reply 2103-4. PubMed ID: 17530659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.